These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 24880569)

  • 1. [Determinants of survival in HIV patients receiving antiretroviral therapy in Goma, Democratic Republic of Congo].
    Akilimali PZ; Mutombo PB; Kayembe PK; Kaba DK; Mapatano MA
    Rev Epidemiol Sante Publique; 2014 Jun; 62(3):201-6. PubMed ID: 24880569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Survival in HIV-1 patients receiving antiretroviral therapy in Morocco].
    Titou H; Baba N; Kasouati J; Oumakir S; Frikh R; Boui M; Hjira N
    Rev Epidemiol Sante Publique; 2018 Sep; 66(5):311-316. PubMed ID: 30177238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disclosure of HIV status and its impact on the loss in the follow-up of HIV-infected patients on potent anti-retroviral therapy programs in a (post-) conflict setting: A retrospective cohort study from Goma, Democratic Republic of Congo.
    Akilimali PZ; Musumari PM; Kashala-Abotnes E; Kayembe PK; Lepira FB; Mutombo PB; Tylleskar T; Ali MM
    PLoS One; 2017; 12(2):e0171407. PubMed ID: 28170410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of Persistent Anaemia in the First Year of Antiretroviral Therapy: A Retrospective Cohort Study from Goma, the Democratic Republic of Congo.
    Akilimali PZ; Kashala-Abotnes E; Musumari PM; Kayembe PK; Tylleskar T; Mapatano MA
    PLoS One; 2015; 10(10):e0140240. PubMed ID: 26474481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiretroviral treatment program retention among HIV-infected children in the Democratic Republic of Congo.
    Ditekemena J; Luhata C; Bonane W; Kiumbu M; Tshefu A; Colebunders R; Koole O
    PLoS One; 2014; 9(12):e113877. PubMed ID: 25541707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality among tuberculosis patients in the Democratic Republic of Congo.
    Henegar C; Behets F; Vanden Driessche K; Tabala M; Bahati E; Bola V; Van Rie A
    Int J Tuberc Lung Dis; 2012 Sep; 16(9):1199-204. PubMed ID: 22871326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virological control during the first 6-18 months after initiating highly active antiretroviral therapy as a predictor for outcome in HIV-infected patients: a Danish, population-based, 6-year follow-up study.
    Lohse N; Kronborg G; Gerstoft J; Larsen CS; Pedersen G; Pedersen C; Sørensen HT; Obel N
    Clin Infect Dis; 2006 Jan; 42(1):136-44. PubMed ID: 16323104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study.
    Etard JF; Ndiaye I; Thierry-Mieg M; Guèye NF; Guèye PM; Lanièce I; Dieng AB; Diouf A; Laurent C; Mboup S; Sow PS; Delaporte E
    AIDS; 2006 May; 20(8):1181-9. PubMed ID: 16691070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality and associated factors after initiation of pediatric antiretroviral treatment in the Democratic Republic of the Congo.
    Callens SF; Shabani N; Lusiama J; Lelo P; Kitetele F; Colebunders R; Gizlice Z; Edmonds A; Van Rie A; Behets F;
    Pediatr Infect Dis J; 2009 Jan; 28(1):35-40. PubMed ID: 19057457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival of HIV-infected patients after starting tuberculosis treatment: a prospective cohort study.
    Maruza M; Albuquerque MF; Braga MC; Barbosa MT; Byington R; Coimbra I; Moura LV; Batista JD; Diniz GT; Miranda-Filho DB; Lacerda HR; Rodrigues LC; Ximenes RA
    Int J Tuberc Lung Dis; 2012 May; 16(5):618-24. PubMed ID: 22410415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa.
    Reddi A; Leeper SC; Grobler AC; Geddes R; France KH; Dorse GL; Vlok WJ; Mntambo M; Thomas M; Nixon K; Holst HL; Karim QA; Rollins NC; Coovadia HM; Giddy J
    BMC Pediatr; 2007 Mar; 7():13. PubMed ID: 17367540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of Survival of HIV Patients Receiving Dolutegravir: A Prospective Cohort Study in Conflict-Affected Bunia, Democratic Republic of Congo.
    Buju RT; Akilimali PZ; Tran NT; Kamangu EN; Mesia GK; Kayembe JMN; Situakibanza HN
    Int J Environ Res Public Health; 2022 Aug; 19(16):. PubMed ID: 36011850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "If I have nothing to eat, I get angry and push the pills bottle away from me": A qualitative study of patient determinants of adherence to antiretroviral therapy in the Democratic Republic of Congo.
    Musumari PM; Feldman MD; Techasrivichien T; Wouters E; Ono-Kihara M; Kihara M
    AIDS Care; 2013; 25(10):1271-7. PubMed ID: 23383757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival and causes of death among HIV-infected patients starting antiretroviral therapy in north-eastern Vietnam.
    Cuong do D; Thorson A; Sönnerborg A; Hoa NP; Chuc NT; Phuc HD; Larsson M
    Scand J Infect Dis; 2012 Mar; 44(3):201-8. PubMed ID: 22122590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence, risk factors and causes of death in an HIV care programme with a large proportion of injecting drug users.
    Spillane H; Nicholas S; Tang Z; Szumilin E; Balkan S; Pujades-Rodriguez M
    Trop Med Int Health; 2012 Oct; 17(10):1255-63. PubMed ID: 22863110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced HIV Disease at Antiretroviral Therapy Initiation and Treatment Outcomes Among Children and Adolescents Compared to Adults Living With HIV in Kinshasa, Democratic Republic of the Congo.
    Chabikuli ON; Ditekemena JD; Sigwadhi LN; Mulenga A; Mboyo A; Bidashimwa D; Nachega JB
    J Int Assoc Provid AIDS Care; 2023; 22():23259582231221955. PubMed ID: 38146172
    [No Abstract]   [Full Text] [Related]  

  • 17. The impact of malnutrition in survival of HIV infected children after initiation of antiretroviral treatment (ART).
    Taye B; Shiferaw S; Enquselassie F
    Ethiop Med J; 2010 Jan; 48(1):1-10. PubMed ID: 20607992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings.
    Bedell R; Heath KV; Hogg RS; Wood E; Press N; Yip B; O'Shaughnessy MV; Montaner JS
    Antivir Ther; 2003 Oct; 8(5):379-84. PubMed ID: 14640384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health-related quality of life and survival among HIV-infected patients receiving highly active antiretroviral therapy: a study of patients in the AIDS Therapy Evaluation in the Netherlands (ATHENA) Cohort.
    de Boer-van der Kolk IM; Sprangers MA; Prins JM; Smit C; de Wolf F; Nieuwkerk PT
    Clin Infect Dis; 2010 Jan; 50(2):255-63. PubMed ID: 20014949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative and evolutionary profile of people infected with HIV on antiretroviral therapy in Kinshasa, Democratic Republic of Congo].
    Koy T; Mukumbi H; Malandala GL; Donnen P; Wilmet-Dramaix M
    Pan Afr Med J; 2014; 19():388. PubMed ID: 25995784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.